World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
47125
World Ranking
9889
National Ranking
5089

David G. Warnock publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David G. Warnock sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 426 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David G. Warnock D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David G. Warnock sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David G. Warnock is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on Medicine and Biochemistry, Genetics and Molecular Biology, with particular emphasis on Physiology, Epidemiology, Organic Chemistry, Molecular Biology, and Rheumatology as key subfields.

The scientist's work centers around topics such as Lysosomal Storage Disorders Research, Carbohydrate Chemistry and Synthesis, Trypanosoma species research and implications, Glycogen Storage Diseases and Myoclonus, Enzyme Production and Characterization, Ginkgo biloba and Cashew Applications, and Cellular transport and secretion.

Warnock has contributed to multiple publications in prominent venues including:

  • Molecular Genetics and Metabolism
  • Journal of Medical Genetics
  • The Nephron journals
  • Journal of the American Society of Nephrology
  • Genetics in Medicine Open

Among recent papers associated with or relevant to their collaborative work are:

  • Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease, 2021, Journal of Medical Genetics
  • Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup, 2020, Journal of Medical Genetics
  • A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm, 2021, Orphanet Journal of Rare Diseases
  • Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study, 2023, Journal of Medical Genetics
  • Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative, 2020, BMJ Open

David G. Warnock's frequent collaborators include researchers such as Derralynn Hughes, Eric Wallace, Raul Chertkoff, Camilla Tøndel, and Sari Alon, reflecting a diverse and multidisciplinary engagement within their research community.

Best Publications

  • Acute Kidney Injury Network: Report of an Initiative to Improve Outcomes in Acute Kidney Injury

    Ravindra L Mehta;John A Kellum;Sudhir V Shah;Bruce A Molitoris

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

    Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward

  • Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel

    Richard A. Shimkets;David G. Warnock;Christopher M. Bositis;Carol Nelson-Williams

  • Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    Pablo E. Pergola;Philip Raskin;Robert D. Toto;Colin J. Meyer

  • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

    Kunihiro Matsushita;Bakhtawar K. Mahmoodi;Bakhtawar K. Mahmoodi;Mark Woodward;Jonathan R. Emberson

  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

    Kunihiro Matsushita;Josef Coresh;Yingying Sang;John Chalmers

  • Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial

    Maryam Banikazemi;Jan Bultas;Stephen Waldek;William R. Wilcox

  • Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.

    Rajiv Agarwal;Allen R Nissenson;Daniel Batlle;Daniel W Coyne

  • Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry

    William R. Wilcox;William R. Wilcox;João Paulo Oliveira;Robert J. Hopkin;Alberto Ortiz

  • Acute Kidney Injury and Mortality in Hospitalized Patients

    Henry E. Wang;Paul Muntner;Glenn M. Chertow;David G. Warnock

  • Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

    Christine M Eng;Dominique P Germain;Maryam Banikazemi;David G Warnock

  • Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

    Carmen A. Peralta;Michael G. Shlipak;Suzanne Judd;Mary Cushman

  • The global burden of chronic kidney disease: estimates, variability and pitfalls

    Richard J. Glassock;David G. Warnock;Pierre Delanaye

  • Liddle's Syndrome Revisited -- A Disorder of Sodium Reabsorption in the Distal Tubule

    Mauricio Botero-Velez;John J. Curtis;David G. Warnock

  • Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

    Manjula Kurella Tamura;Virginia Wadley;Virginia Wadley;Kristine Yaffe;Leslie A. McClure

  • Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

    Raphael J. Schiffmann;David G. Warnock;Maryam Banikazemi;Jan Bultas

  • Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

    Dominique P Germain;Joel Charrow;Robert J Desnick;Nathalie Guffon

  • Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients

    Kamyar Kalantar-Zadeh;Deborah L. Regidor;Charles J. McAllister;Beckie Michael

  • Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction

    Britt B. Newsome;David G. Warnock;William M. McClellan;Charles A. Herzog

  • Agalsidase-Beta Therapy for Advanced Fabry Disease

    Maryam Banikazemi;Jan Bultas;Stephen Waldek;William R. Wilcox

Frequent Co-Authors

Paul Muntner
Paul Muntner University of Alabama at Birmingham
William M. McClellan
William M. McClellan Emory University
Christoph Wanner
Christoph Wanner University of Würzburg
William R. Wilcox
William R. Wilcox Emory University
Alberto Ortiz
Alberto Ortiz Autonomous University of Madrid
George Howard
George Howard University of Alabama at Birmingham
Mary Cushman
Mary Cushman University of Vermont
Daniel G. Bichet
Daniel G. Bichet University of Montreal
Ravindra L. Mehta
Ravindra L. Mehta University of California, San Diego
Monika M. Safford
Monika M. Safford Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in a medical career but want to explore alternative or related options, there are several online degrees and pathways to consider. One popular choice is online lpn programs, which provide a fast and flexible route into practical nursing roles. For nurses looking to specialize further, the shortest post master's pmhnp online programs offer a streamlined pathway to become a Psychiatric Mental Health Nurse Practitioner.

Not all healthcare roles require direct patient care. A bachelors in health administration can set you on course for leadership roles within clinics, hospitals, or managed care organizations. For those seeking advanced positions, there are also online mha programs affordable that focus on strategic management and operational leadership in healthcare settings.

Each of these online degree options offers valuable flexibility and can help you enter or advance in the rapidly growing healthcare field, even if you want an alternative to the traditional MD route.

Best Scientists Citing David G. Warnock

Trending Scientists

Recently Published Articles